Hao Rui Zhi - Net Worth and Insider Trading

Hao Rui Zhi Net Worth

The estimated net worth of Hao Rui Zhi is at least $15 Million dollars as of 2024-11-13. Hao Rui Zhi is the Directors, Directors, and Executives of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd and owns about 446,600 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) stock worth over $15 Million. Details can be seen in Hao Rui Zhi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hao Rui Zhi has not made any transactions after 2022-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Hao Rui Zhi

Hao Rui Zhi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hao Rui Zhi owns 1 companies in total, including Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) .

Click here to see the complete history of Hao Rui Zhi’s form 4 insider trades.

Insider Ownership Summary of Hao Rui Zhi

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300937	Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd	2022-06-13	Directors & Directors & and Executives

Hao Rui Zhi Latest Holdings Summary

Hao Rui Zhi currently owns a total of 1 stock. Hao Rui Zhi owns 446,600 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) as of June 13, 2022, with a value of $15 Million.

Latest Holdings of Hao Rui Zhi

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300937	Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd	2022-06-13	446,600	34.15	15,251,390

Holding Weightings of Hao Rui Zhi

Hao Rui Zhi Form 4 Trading Tracker

According to the SEC Form 4 filings, Hao Rui Zhi has made a total of 4 transactions in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd is the sale of 5,000 shares on June 13, 2022, which brought Hao Rui Zhi around $147,100.

Insider Trading History of Hao Rui Zhi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hao Rui Zhi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hao Rui Zhi Ownership Network

Ownership Network List of Hao Rui Zhi

No Data

Ownership Network Relation of Hao Rui Zhi

Hao Rui Zhi Owned Company Details

What does Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd do?

Who are the key executives at Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd?

Hao Rui Zhi is the Directors & Directors & and Executives of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd. Other key executives at Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd include Supervisors tian wen shu , and Executives Lei Qi Gang .

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) Insider Trades Summary

Over the past 18 months, Hao Rui Zhi made no insider transaction in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937). Other recent insider transactions involving Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) include a net sale of 1,203,000 shares made by tian wen shu ,

In summary, during the past 3 months, insiders sold 0 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,203,000 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,203,000 shares.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd Insider Transactions

No Available Data

Hao Rui Zhi Mailing Address

Above is the net worth, insider trading, and ownership report for Hao Rui Zhi. Currently GuruFocus does not have mailing address information for Hao Rui Zhi.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.